KYOWA KIRIN, INC.

Lobbying client · New Jersey · filed 2026 to 2026

Pharmaceutical company

$40,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (71534), not by name.

Firms hired 1

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS $40,000 3 filings

Reported by year 1 year

2026 $40,000 3 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

Executive Office of the President (EOP) 1
Health & Human Services, Dept of (HHS) 1

Recent filings 3 total

Q2

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

2nd Quarter (Apr 1 - June 30) 2026 · $30,000 income · posted Jul 15, 2026

View → Q1Y

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

1st Quarter (Jan 1 - Mar 31) 2026 · $10,000 income · posted Apr 15, 2026

View → RR

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

1st Quarter (Jan 1 - Mar 31) 2026 · posted Mar 2, 2026

View →

Foreign entities disclosed 1

KYOWA KIRIN CO., LTD Japan named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.